6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection

Graduate School of East-West Medical Science, Kyung Hee University Global Campus, #1732 Deogyeong-daero, Giheung-gu, Yongin, Gyeonggi-do 446-701, Republic of Korea.
Neuropharmacology (Impact Factor: 4.82). 03/2012; 63(2):211-23. DOI: 10.1016/j.neuropharm.2012.03.016
Source: PubMed

ABSTRACT Inflammatory processes in the central nervous system play an important role in a number of neurodegenerative diseases mediated by microglial activation, which results in neuronal cell death. Microglia act in immune surveillance and host defense while resting. When activated, they can be deleterious to neurons, even resulting in neurodegeneration. Therefore, the inhibition of microglial activation is considered a useful strategy in searching for neuroprotective agents. In this study, we investigated the effects of 6-shogaol, a pungent agent from Zingiber officinale Roscoe, on microglia activation in BV-2 and primary microglial cell cultures. 6-Shogaol significantly inhibited the release of nitric oxide (NO) and the expression of inducible nitric oxide synthase (iNOS) induced by lipopolysaccharide (LPS). The effect was better than that of 6-gingerol, wogonin, or N-monomethyl-l-arginine, agents previously reported to inhibit nitric oxide. 6-Shogaol exerted its anti-inflammatory effects by inhibiting the production of prostaglandin E(2) (PGE(2)) and proinflammatory cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), and by downregulating cyclooxygenase-2 (COX-2), p38 mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-κB) expression. In addition, 6-shogaol suppressed the microglial activation induced by LPS both in primary cortical neuron-glia culture and in an in vivo neuroinflammatory model. Moreover, 6-shogaol showed significant neuroprotective effects in vivo in transient global ischemia via the inhibition of microglia. These results suggest that 6-shogaol is an effective therapeutic agent for treating neurodegenerative diseases.

Download full-text


Available from: Dong Hyun Kim, Dec 26, 2013
    • "A recent study has demonstrated that 6-shogaol, not 6-gingerol, suppresses LPS-induced iNOS, COX-2, IL- 1b and TNF-a expression through downregulation of p38 mitogenactivated protein kinase (MAPK) signalling and NF-jB activation in both of BV2 and primary microglial cells (Ha et al., 2012). Additionally , the inhibition of 6-shogaol on microglial activation mitigated ischemia-induced neurological damages in vivo has been published (Ha et al., 2012). Although 6-gingerol and 6-shogaol have been demonstrated, respectively, to attenuate LPS-induced iNOS and COX-2 expression in murine macrophages by blocking NF-jB activation (Lee, Lee, Chen, & Chang, 2009; Pan et al., 2008; Tripathi, Fig. 4. Representative HPLC chromatogram of the selected gingerol-related compounds (A) and fresh ginger ethanolic extract (B). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Uncontrolled activation of microglia contributes to neuroinflammation, which is highly involved in the development of neurodegenerative diseases. Although cinnamon has neuro-protective properties, its capacity to inhibit neuroinflammation has not been investigated and its active compounds remain unclear. Therefore, the composition of cinnamon extract was analysed by LC-MS and the ability of cinnamon and its main constituents to inhibit neuroinflammation was evaluated using a lipopolysaccharide (LPS)-activated BV2 microglia culture system. In total, 50μg/mL cinnamon extract decreased significantly the production and expression of nitric oxide (NO), interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α in LPS-activated BV2 microglia. Blocking of nuclear factor-κB (NF-κB) activation was the most likely mechanism responsible for inhibition by cinnamon of neuroinflammation. Among the eight tested compounds, cinnamaldehyde had the greatest anti-neuroinflammatory capacity. Experimental results suggest that cinnamon may have a potential therapeutic effect against neurodegenerative diseases and its potent anti-neuroinflammatory capacity was primarily attributed to cinnamaldehyde.
    Food Chemistry 06/2013; 138(4):2275-82. DOI:10.1016/j.foodchem.2012.12.020 · 3.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The resort worldwide to edible medicinal plants for medical care has increased significantly during the last few years. Currently, there is a renewed interest in the search for new phytochemicals that could be developed as useful anti-inflammatory and anti-allergic agents to reduce the risk of many diseases. The activation of nuclear transcription factor-kappa B (NF-κB) has now been linked to a variety of inflammatory diseases, while data from numerous studies underline the importance of phytochemicals in inhibiting the pathway that activates this transcription factor. Moreover, the incidence of type I allergic disorders has been increasing worldwide, particularly, the hypersensitivity to food. Thus, a good number of plant products with anti-inflammatory and anti-allergic activity have been documented, but very few of these compounds have reached clinical use and there is scant scientific evidence that could explain their mode of action. Therefore, this paper intends to review the most salient recent reports on the anti-inflammatory and anti-allergic properties of phytochemicals and the molecular mechanisms underlying these properties.
    Molecules 11/2012; 18(1):322-53. DOI:10.3390/molecules18010322 · 2.42 Impact Factor
  • Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 10/2012; DOI:10.1016/j.fct.2012.10.019 · 2.61 Impact Factor
Show more